Daewoong Pharmaceutical logo

Daewoong Pharmaceutical

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Daewoong Pharmaceutical is a healthcare company that provides pharmaceuticals solutions and services for consumers.

Investor Profile

Daewoong Pharmaceutical has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, South Korea.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • South Korea (50%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Life Science
  • Therapeutics
  • Food Processing
  • Livestock
  • Meat And Poultry
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Daewoong Pharmaceutical frequently co-invest with?

Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 1
ThreeD Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
HanAll Biopharma
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
MF
North America, Virginia, United States, Springfield
Co-Investments: 1
BV
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Genting Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Daewoong Pharmaceutical?

CellMEAT

Gwangju, Kwangju-jikhalsi, South Korea

CellMEAT is a company that provides protein production services.

Food ProcessingLivestockMeat and Poultry
Series AMay 24, 2023
Amount Raised: $13,193,628
Turn.bio

Mountain View, California, United States

Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases.

BiotechnologyGeneticsHealth CareLife ScienceTherapeutics
Series UnknownApr 11, 2022

Find More Investors Like Daewoong Pharmaceutical

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Daewoong Pharmaceutical | Pipeseed